Browsing Tag
Columbus
14 posts
Vext’s Ohio expansion offsets Arizona retreat as Q2 EBITDA rises 22% sequentially
Vext Science held quarterly revenue near US$12.1 million and improved adjusted EBITDA sequentially as Ohio retail growth offset the deliberate wind-down of Arizona cultivation and wholesale operations.
Duos Technologies’ $500m AI contracts turn 55 MW buildout into an execution test
Duos Technologies signs $500 million of Axe Compute AI hosting deals, but 55 MW of construction, financing and acceptance make execution the real $DUOT test.
Anduril targets $100bn valuation as defence-tech funding tests public-market reality
Anduril Industries is reportedly in talks for a fresh funding round at a valuation near $100 billion, turning the defence-technology startup into a private-market challenger to established military contractors.
LXP Industrial (NYSE: LXP) to go private as Brookfield and CPP Investments strike $5.2bn Sunbelt logistics deal
Brookfield and CPP Investments to take LXP Industrial private at $61.20 cash in a $5.2 billion deal, with a 40-day go-shop live and LXP's 33-year dividend streak paused.
MasTec’s $1.65bn Superior deal targets the electrical bottleneck behind AI data centres
MasTec’s acquisition of Superior Group expands the contractor from grid and fibre connections into the complex electrical systems inside hyperscale AI data centres.
FirstEnergy (NYSE: FE) secures PJM mandate for $950m transmission build across Ohio and Pennsylvania amid accelerating load growth
FirstEnergy Transmission wins PJM-approved projects worth $950M in Ohio and Pennsylvania. What it means for grid reliability, load growth, and FE investors. Read more.
Huntington Bancshares gets final regulatory approval to absorb Cadence Bank in $7.4B all-stock deal
Find out how Huntington’s $7.4B merger with Cadence Bank reshapes U.S. regional banking and why Texas and Mississippi are now strategic battlegrounds.
Earnings boost across all divisions: why Steel Dynamics says Q3 will top Wall Street expectations
Steel Dynamics lifts Q3 earnings forecast to $2.60–$2.64 per share, with all divisions showing growth. See what this means for STLD stock today.
Hikma Pharmaceuticals commits to $1 billion U.S. generics expansion amid strategic reshoring efforts
Hikma Pharmaceuticals (LSE: HIK) will invest $1B in U.S. manufacturing and R&D to strengthen its position in the generics market and address domestic drug shortages.
Indo Count Industries expands in U.S. utility bedding market with key acquisitions
Indo Count Industries Ltd., a leading company in bed linen, has announced a strategic move to further penetrate…